Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 24 results:
Author [ Title] Type Year Filters: Author is Boutari, Chrysoula [Clear All Filters]
(2019).
Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?.
J Neurol Neurosurg Psychiatry. 88(3), 249-253.
(2017). SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature..
Curr Pharm Des. 23(10), 1510-1521.
(2017). Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome..
World J Gastroenterol. 21(25), 7860-8.
(2015). Renovascular Hypertension: Novel Insights..
Curr Hypertens Rev. 16(1), 24-29.
(2020). Renovascular Hypertension: Novel Insights:.
Current Hypertension Reviews. 15,
(2019). Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?.
J Clin Hypertens (Greenwich). 18(8), 828.
(2016). Predictive value of the ankle brachial index in patients with acute ischemic stroke..
Vasa. 43(1), 55-61.
(2014). PATHWAY-2: spironolactone for resistant hypertension..
Lancet. 387(10026), 1371-1372.
(2016).
(2019).
Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun..
Curr Pharm Des. 23(10), 1540-1550.
(2017). Erectile dysfunction in chronic kidney disease: From pathophysiology to management..
World J Nephrol. 4(3), 379-87.
(2015). The effect of underweight on female and male reproduction..
Metabolism. 107, 154229.
(2020).
(2013).
(2018). Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive Function..
JAMA Intern Med. 176(3), 409.
(2016). Depression in hypertensive patients: the role of comorbidities..
J Hypertens. 34(7), 1441.
(2016). Current challenges in antihypertensive treatment in the elderly..
Pol Arch Med Wewn. 126(7-8), 540-51.
(2016). Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis..
Metabolism. 154203.
(2020). Clinical Value of Measuring the Renin/Aldosterone Levels: Optimising the Management of Uncontrolled/Resistant Hypertension..
Curr Vasc Pharmacol. 16(1), 10-14.
(2017). Canagliflozin and Hypertension: Is It the Optimal Choice for All Hypertensive Patients?.
J Clin Hypertens (Greenwich). 18(10), 1073.
(2016). Blood pressure and cardiovascular outcomes: a closer look..
Lancet. 389(10076), 1295-1296.
(2017). Antihypertensive Drug-Related Side Effects: Is It the Unique Indicator for Nonadherence?.
Am J Hypertens. 29(5), 662.
(2016).
(2021).